Literature DB >> 19789385

Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.

Jordan A Shavit1, Ani Manichaikul, Heidi L Lemmerhirt, Karl W Broman, David Ginsburg.   

Abstract

Type 1 von Willebrand disease (VWD) is the most common inherited human bleeding disorder. However, diagnosis is complicated by incomplete penetrance and variable expressivity, as well as wide variation in von Willebrand factor (VWF) levels among the normal population. Previous work has exploited the highly variable plasma VWF levels among inbred strains of mice to identify 2 major regulators, Mvwf1 and Mvwf2 (modifier of VWF). Mvwf1 is a glycosyltransferase and Mvwf2 is a natural variant in Vwf that alters biosynthesis. We report the identification of an additional alteration at the Vwf locus (Mvwf5), as well as 2 loci unlinked to Vwf (Mvwf6-7) using a backcross approach with the inbred mouse strains WSB/EiJ and C57BL/6J. Through positional cloning, we show that Mvwf5 is a cis-regulatory variant that alters Vwf mRNA expression. A similar mechanism could potentially explain a significant percentage of human VWD cases, especially those with no detectable mutation in the VWF coding sequence. Mvwf6 displays conservation of synteny with potential VWF modifier loci identified in human pedigrees, suggesting that its ortholog may modify VWF in human populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789385      PMCID: PMC2796139          DOI: 10.1182/blood-2009-07-233213

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Genetic determinants of hemostasis phenotypes in Spanish families.

Authors:  J C Souto; L Almasy; M Borrell; M Garí; E Martínez; J Mateo; W H Stone; J Blangero; J Fontcuberta
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.

Authors:  R A Kraaijenhagen; P S in't Anker; M M Koopman; P H Reitsma; M H Prins; A van den Ende; H R Büller
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

3.  High levels of factor VIII and venous thrombosis.

Authors:  F R Rosendaal
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

4.  A statistical framework for quantitative trait mapping.

Authors:  S Sen; G A Churchill
Journal:  Genetics       Date:  2001-09       Impact factor: 4.562

5.  Initial sequencing and comparative analysis of the mouse genome.

Authors:  Robert H Waterston; Kerstin Lindblad-Toh; Ewan Birney; Jane Rogers; Josep F Abril; Pankaj Agarwal; Richa Agarwala; Rachel Ainscough; Marina Alexandersson; Peter An; Stylianos E Antonarakis; John Attwood; Robert Baertsch; Jonathon Bailey; Karen Barlow; Stephan Beck; Eric Berry; Bruce Birren; Toby Bloom; Peer Bork; Marc Botcherby; Nicolas Bray; Michael R Brent; Daniel G Brown; Stephen D Brown; Carol Bult; John Burton; Jonathan Butler; Robert D Campbell; Piero Carninci; Simon Cawley; Francesca Chiaromonte; Asif T Chinwalla; Deanna M Church; Michele Clamp; Christopher Clee; Francis S Collins; Lisa L Cook; Richard R Copley; Alan Coulson; Olivier Couronne; James Cuff; Val Curwen; Tim Cutts; Mark Daly; Robert David; Joy Davies; Kimberly D Delehaunty; Justin Deri; Emmanouil T Dermitzakis; Colin Dewey; Nicholas J Dickens; Mark Diekhans; Sheila Dodge; Inna Dubchak; Diane M Dunn; Sean R Eddy; Laura Elnitski; Richard D Emes; Pallavi Eswara; Eduardo Eyras; Adam Felsenfeld; Ginger A Fewell; Paul Flicek; Karen Foley; Wayne N Frankel; Lucinda A Fulton; Robert S Fulton; Terrence S Furey; Diane Gage; Richard A Gibbs; Gustavo Glusman; Sante Gnerre; Nick Goldman; Leo Goodstadt; Darren Grafham; Tina A Graves; Eric D Green; Simon Gregory; Roderic Guigó; Mark Guyer; Ross C Hardison; David Haussler; Yoshihide Hayashizaki; LaDeana W Hillier; Angela Hinrichs; Wratko Hlavina; Timothy Holzer; Fan Hsu; Axin Hua; Tim Hubbard; Adrienne Hunt; Ian Jackson; David B Jaffe; L Steven Johnson; Matthew Jones; Thomas A Jones; Ann Joy; Michael Kamal; Elinor K Karlsson; Donna Karolchik; Arkadiusz Kasprzyk; Jun Kawai; Evan Keibler; Cristyn Kells; W James Kent; Andrew Kirby; Diana L Kolbe; Ian Korf; Raju S Kucherlapati; Edward J Kulbokas; David Kulp; Tom Landers; J P Leger; Steven Leonard; Ivica Letunic; Rosie Levine; Jia Li; Ming Li; Christine Lloyd; Susan Lucas; Bin Ma; Donna R Maglott; Elaine R Mardis; Lucy Matthews; Evan Mauceli; John H Mayer; Megan McCarthy; W Richard McCombie; Stuart McLaren; Kirsten McLay; John D McPherson; Jim Meldrim; Beverley Meredith; Jill P Mesirov; Webb Miller; Tracie L Miner; Emmanuel Mongin; Kate T Montgomery; Michael Morgan; Richard Mott; James C Mullikin; Donna M Muzny; William E Nash; Joanne O Nelson; Michael N Nhan; Robert Nicol; Zemin Ning; Chad Nusbaum; Michael J O'Connor; Yasushi Okazaki; Karen Oliver; Emma Overton-Larty; Lior Pachter; Genís Parra; Kymberlie H Pepin; Jane Peterson; Pavel Pevzner; Robert Plumb; Craig S Pohl; Alex Poliakov; Tracy C Ponce; Chris P Ponting; Simon Potter; Michael Quail; Alexandre Reymond; Bruce A Roe; Krishna M Roskin; Edward M Rubin; Alistair G Rust; Ralph Santos; Victor Sapojnikov; Brian Schultz; Jörg Schultz; Matthias S Schwartz; Scott Schwartz; Carol Scott; Steven Seaman; Steve Searle; Ted Sharpe; Andrew Sheridan; Ratna Shownkeen; Sarah Sims; Jonathan B Singer; Guy Slater; Arian Smit; Douglas R Smith; Brian Spencer; Arne Stabenau; Nicole Stange-Thomann; Charles Sugnet; Mikita Suyama; Glenn Tesler; Johanna Thompson; David Torrents; Evanne Trevaskis; John Tromp; Catherine Ucla; Abel Ureta-Vidal; Jade P Vinson; Andrew C Von Niederhausern; Claire M Wade; Melanie Wall; Ryan J Weber; Robert B Weiss; Michael C Wendl; Anthony P West; Kris Wetterstrand; Raymond Wheeler; Simon Whelan; Jamey Wierzbowski; David Willey; Sophie Williams; Richard K Wilson; Eitan Winter; Kim C Worley; Dudley Wyman; Shan Yang; Shiaw-Pyng Yang; Evgeny M Zdobnov; Michael C Zody; Eric S Lander
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 6.  Von Willebrand disease type 1: a diagnosis in search of a disease.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

7.  Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.

Authors:  Juan Carlos Souto; Laura Almasy; Jose Manuel Soria; Alfonso Buil; William Stone; Mark Lathrop; John Blangero; Jordi Fontcuberta
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

8.  The genetics of haemostasis: a twin study.

Authors:  M de Lange; H Snieder; R A Ariëns; T D Spector; P J Grant
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 9.  Getting at the variable expressivity of von Willebrand disease.

Authors:  G Levy; D Ginsburg
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 10.  von Willebrand factor, endothelial dysfunction, and cardiovascular disease.

Authors:  U M Vischer
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

View more
  13 in total

1.  A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.

Authors:  Andrew Yee; Robert D Gildersleeve; Shufang Gu; Colin A Kretz; Beth M McGee; Keisha M Carr; Steven W Pipe; David Ginsburg
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.

Authors:  Bagirath Gangadharan; Mathieu Ing; Sandrine Delignat; Ivan Peyron; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

3.  A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.

Authors:  Niamh O'Regan; Kristina Gegenbauer; Jamie M O'Sullivan; Sanaz Maleki; Teresa M Brophy; Niall Dalton; Alain Chion; Padraic G Fallon; Georges E Grau; Ulrich Budde; Owen P Smith; Alister G Craig; Roger J S Preston; James S O'Donnell
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

4.  Modeling Disorders of Blood Coagulation in the Zebrafish.

Authors:  Colin A Kretz; Angela C Weyand; Jordan A Shavit
Journal:  Curr Pathobiol Rep       Date:  2015-06

5.  Sequence variation at multiple loci influences red cell hemoglobin concentration.

Authors:  Luanne L Peters; Jordan A Shavit; Amy J Lambert; Shirng-Wern Tsaih; Qian Li; Zhiguang Su; Magalie S Leduc; Beverly Paigen; Gary A Churchill; David Ginsburg; Carlo Brugnara
Journal:  Blood       Date:  2010-09-10       Impact factor: 22.113

6.  The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.

Authors:  Tania N Petruzziello-Pellegrini; Darren A Yuen; Andrea V Page; Sajedabanu Patel; Anna M Soltyk; Charles C Matouk; Dennis K Wong; Paul J Turgeon; Jason E Fish; J J David Ho; Brent M Steer; Vahid Khajoee; Jayesh Tigdi; Warren L Lee; David G Motto; Andrew Advani; Richard E Gilbert; S Ananth Karumanchi; Lisa A Robinson; Phillip I Tarr; W Conrad Liles; James L Brunton; Philip A Marsden
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

7.  An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Authors:  Viviana Daidone; Lisa Gallinaro; Maria Grazia Cattini; Elena Pontara; Antonella Bertomoro; Antonio Pagnan; Alessandra Casonato
Journal:  Haematologica       Date:  2011-03-10       Impact factor: 9.941

8.  Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Authors:  Junmei Chen; Jesse D Hinckley; Sandra Haberichter; Paula Jacobi; Robert Montgomery; Veronica H Flood; Randall Wong; Gianluca Interlandi; Dominic W Chung; José A López; Jorge Di Paola
Journal:  Blood       Date:  2015-05-27       Impact factor: 22.113

9.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

10.  Mouse chromosome 17 candidate modifier genes for thrombosis.

Authors:  Qila Sa; Erika Hart; Joseph H Nadeau; Jane L Hoover-Plow
Journal:  Mamm Genome       Date:  2010-08-11       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.